Poster Abstract Session:
148. HIV: Resistance
Friday, October 9, 2015: 12:30 PM-2:00 PM
Room: Poster Hall

Learning Objectives:


Tracks: Pediatric ID, HIV-STD-TB, Adult ID

Responses to first-line antiretroviral therapy (ART) in patients with isolated NNRTI transmitted drug resistance (TDR)
Dana Clutter, MD ; Jeffrey Fessel, MD ; Soo-Yon Rhee, MS ; Daniel Klein, MD ; Michael Silverberg, PhD, MPH ; Robert Shafer, MD
Pre-switch Resistance to Complera and Stribild and its Impact on HIV Virological Outcome
Rebecca Reece, MD ; Matthew D'antuono, BS ; Karen Tashima, MD ; Rami Kantor, MD
  • Poster_1084.pdf (960.8 kB)
  • Impact of Low-Level Viremia (LLV) on Virologic Outcomes in HIV-Positive Patients
    Brooke Stevens, PharmD ; Eric Farmer, PharmD, BCPS ; Lisa Fletcher, PharmD, BCPS ; Melody Berg, PharmD, BCPS AQ-ID
  • LLV_IDWeek_BStevens.pdf (221.3 kB)
  • Virologic Effectiveness of Abacavir/Lamivudine with Darunavir versus                             Other Protease Inhibitors in Treatment-Experienced HIV-Infected Patients in Clinical                             Practice
    Philip Lackey, MD ; Anthony Mills, MD ; Felix Carpio, MD ; Ricky Hsu, MD ; Edwin Dejesus, MD, FACP, FIDSA ; Gerald Pierone, MD ; Cassidy Henegar, PhD ; Emily Brouwer, PharmD, PhD ; Jennifer Fusco, BS ; Gregory Fusco, MD, MPH ; Michael Wohlfeiler, MD
  • Epividian_ID-Week-8x4_CROPS.pdf (668.1 kB)
  • A Five Residue Insertion between Codons 28 and 29 of the HIV-1 Protease Gene Reduces the Replicative Capacity of the Virus
    Eunice Ann Wong, MD ; Cathy Mcleod, BS ; Bradley Keusch, BS ; Benjamin Kuiper, BS ; Iulia Kovari, PhD ; Hossein Salimnia, Ph.D. ; Jennifer Veltman, MD ; Ladislau Kovari, Ph.D.

    CME Credits:

    ACPE Credits:

    ACPE Number:

    Findings in the abstracts are embargoed until 12:01 a.m. PDT, Wednesday Oct. 7th with the exception of research findings presented at the IDWeek press conferences.